First Time Loading...

Cardinal Health Inc
NYSE:CAH

Watchlist Manager
Cardinal Health Inc Logo
Cardinal Health Inc
NYSE:CAH
Watchlist
Price: 112.54 USD 0.84% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, c... [ Read More ]

The intrinsic value of one CAH stock under the Base Case scenario is 272.38 USD. Compared to the current market price of 112.54 USD, Cardinal Health Inc is Undervalued by 59%.

Key Points:
CAH Intrinsic Value
Base Case
272.38 USD
Undervaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Cardinal Health Inc

Backtest CAH Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CAH stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Cardinal Health Raises Fiscal '24 EPS and Cash Flow Outlook
2024-Q2 Earnings Call

Cardinal Health Raises Fiscal '24 EPS and Cash Flow Outlook

Cardinal Health experienced profit growth in both its Pharma and Medical segments in Q2, with the Pharma segment reaffirming its 7% to 9% growth projection for fiscal '24. The Medical segment saw a revenue growth trend change positively and continued momentum, which contributed to their overall results and the raised fiscal guidance. The company raised its EPS guidance to $7.20 to $7.35 and its adjusted free cash flow forecast to $2 billion to $2.3 billion, reflecting strong first-half performance and increased confidence going forward. The firm ended the quarter with solid cash reserves of $4.6 billion and is planning to acquire Specialty Networks to complement its growth strategy.

Financials

Balance Sheet Decomposition
Cardinal Health Inc

Current Assets 37.7B
Cash & Short-Term Investments 4.6B
Receivables 11.8B
Other Current Assets 21.3B
Non-Current Assets 8.9B
PP&E 2.4B
Intangibles 5.4B
Other Non-Current Assets 1.1B
Current Liabilities 38.3B
Accounts Payable 34.3B
Accrued Liabilities 2.8B
Other Current Liabilities 1.2B
Non-Current Liabilities 11.7B
Long-Term Debt 3.5B
Other Non-Current Liabilities 8.2B
Efficiency

Earnings Waterfall
Cardinal Health Inc

Revenue
216.1B USD
Cost of Revenue
-208.9B USD
Gross Profit
7.2B USD
Operating Expenses
-5.2B USD
Operating Income
2B USD
Other Expenses
-1.4B USD
Net Income
639m USD

Free Cash Flow Analysis
Cardinal Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

CAH Profitability Score
Profitability Due Diligence

Cardinal Health Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
50/100
Profitability
Score

Cardinal Health Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

CAH Solvency Score
Solvency Due Diligence

Cardinal Health Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Negative Net Debt
Short-Term Solvency
67/100
Solvency
Score

Cardinal Health Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CAH Price Targets Summary
Cardinal Health Inc

Wall Street analysts forecast CAH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAH is 117.59 USD with a low forecast of 96.96 USD and a high forecast of 139.65 USD.

Lowest
Price Target
96.96 USD
14% Downside
Average
Price Target
117.59 USD
4% Upside
Highest
Price Target
139.65 USD
24% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

CAH Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

CAH Price
Cardinal Health Inc

1M 1M
+1%
6M 6M
+29%
1Y 1Y
+56%
3Y 3Y
+94%
5Y 5Y
+174%
10Y 10Y
+111%
Annual Price Range
112.54
52w Low
71.99
52w High
115.62
Price Metrics
Average Annual Return 18.19%
Standard Deviation of Annual Returns 23.01%
Max Drawdown -16%
Shares Statistics
Market Capitalization 27.5B USD
Shares Outstanding 243 232 992
Percentage of Shares Shorted 5.85%

CAH Return Decomposition
Main factors of price return

What is price return decomposition?

CAH News

Other Videos

Last Important Events
Cardinal Health Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Cardinal Health Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Cardinal Health Inc Logo
Cardinal Health Inc

Country

United States of America

Industry

Health Care

Market Cap

27.5B USD

Dividend Yield

1.78%

Description

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 47,300 full-time employees. The firm operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.

Contact

OHIO
Dublin Ohio
7000 Cardinal Pl
+16147573033.0
https://www.cardinalhealth.com/en.html

IPO

1983-08-04

Employees

47 300

Officers

CEO & Director
Mr. Jason M. Hollar
Chief Financial Officer
Mr. Aaron E. Alt
Chief Legal & Compliance Officer
Ms. Jessica L. Mayer
Chief Executive Officer of Medical Segment
Mr. Stephen M. Mason
Chief Executive Officer of Pharmaceutical Segment
Ms. Deborah L. Weitzman
Senior Vice President
Ms. Patricia M. English
Show More
Senior VP & Chief Accounting Officer
Ms. Mary C. Scherer
Executive VP, Chief Information Officer & Customer Support Services
Ms. Michelle D. Greene
Vice President of Investor Relations
Matt Sims
Chief Human Resources Officer
Ms. Ola M. Snow
Show Less

See Also

Discover More
What is the Intrinsic Value of one CAH stock?

The intrinsic value of one CAH stock under the Base Case scenario is 272.38 USD.

Is CAH stock undervalued or overvalued?

Compared to the current market price of 112.54 USD, Cardinal Health Inc is Undervalued by 59%.